OncoDaily’s Post

View organization page for OncoDaily, graphic

26,490 followers

Delivering chemo via HER2- and Trop2-targeted Antibody-drug conjugates (ADCs) has reshaped the way we treat Metastatic breast cancer (MBC) - Paolo Tarantino Ilana Schlam #cancer #chemotherapy #antibodydrug #europeaninstituteofofoncology #metastaticcancer #researcher #oncology #oncodaily

Paolo Tarantino: Delivering chemo via HER2- and Trop2-targeted Antibody-drug conjugates (ADCs) has reshaped the way we treat Metastatic breast cancer (MBC) - Oncodaily | Oncology News, Insights, Stories

Paolo Tarantino: Delivering chemo via HER2- and Trop2-targeted Antibody-drug conjugates (ADCs) has reshaped the way we treat Metastatic breast cancer (MBC) - Oncodaily | Oncology News, Insights, Stories

oncodaily.com

To view or add a comment, sign in

Explore topics